O'Keefe D'elia
Psychiatric/Mental Health · Orlando, FLNPI 1316517543
Payments from drug & device makers
Across 191 payments — averaging $20.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$878
- Johnson & Johnson$854
- Teva Pharmaceuticals USA, Inc.$639
- E.r. Squibb & Sons, L.L.C.$393
- Otsuka America Pharmaceutical, Inc.$376
- Alkermes, Inc.$193
- plus $500 from 7 others
What the payments were for
- Food & beverage$3,72197%
- Education$1113%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 45 | $878 |
| Johnson & Johnson | 37 | $854 |
| Teva Pharmaceuticals USA, Inc. | 38 | $639 |
| E.r. Squibb & Sons, L.L.C. | 17 | $393 |
| Otsuka America Pharmaceutical, Inc. | 19 | $376 |
| Alkermes, Inc. | 9 | $193 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $144 |
| Vanda Pharmaceuticals Inc. | 7 | $116 |
| Indivior Inc. | 5 | $91 |
| Lundbeck LLC | 2 | $65 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Noven Therapeutics, LLC | 1 | $22 |
| AbbVie | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COBENFY$127
How this compares
$3,833 in reported general payments places this provider in the 85th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 153 | $450,507 |
| AristadaAripiprazole Lauroxil | 45 | $131,273 |
| Invega TrinzaPaliperidone Palmitate | 15 | $125,517 |
| IngrezzaValbenazine Tosylate | 15 | $119,244 |
| VraylarCariprazine Hcl | 27 | $35,193 |
| VivitrolNaltrexone Microspheres | 11 | $18,097 |
| LybalviOlanzapine/Samidorphan Malate | 11 | $16,362 |
| TrintellixVortioxetine Hydrobromide | 23 | $11,336 |
| Lurasidone Hcl | 15 | $6,063 |
| Clozapine | 156 | $4,879 |
| Paliperidone ErPaliperidone | 47 | $1,526 |
| Divalproex Sodium ErDivalproex Sodium | 84 | $1,352 |
| Hydroxyzine Pamoate | 62 | $1,069 |
| Olanzapine | 44 | $953 |
| Haloperidol | 17 | $822 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Invega Trinza | $854 | $576,024168 claims |
| Alkermes, Inc.Aristada, Vivitrol, Lybalvi | $193 | $165,73167 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $878 | $119,24415 claims |
| AbbVieVraylar | $13 | $35,19327 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Orlando
- Elizabeth GueldeOrlando$48K
- Amber SiegelOrlando$17K
- Orville MurrayOrlando$13K
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Cheedy JajaTampa$266K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.